Alpine Global Management, LLC Sorrento Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $120,554 - $298,128	162,912 New	162,912 $144,000
Q1 2022 May 13, 2022	SELL	$2.0 - $4.9 $51,786 - $126,875	-25,893 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $61,566 - $95,725	13,240 Added 104.64%	25,893 $120,000
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $93,758 - $139,056	12,653 New	12,653 $114,000
Q4 2020 Feb 12, 2021	SELL	$5.76 - $11.95 $173,952 - $360,890	-30,200 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$6.17 - $18.82 $186,334 - $568,364	30,200 New	30,200 $337,000
Q1 2020 Apr 09, 2020	SELL	$1.57 - $4.76 $29,250 - $88,683	-18,631 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$1.45 - $4.17 $27,014 - $77,691	18,631 New	18,631 $63,000
Q1 2019 May 10, 2019	SELL	$1.86 - $5.94 $275,642 - $880,278	-148,195 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.24 $297,871 - $628,346	148,195 New	148,195 $356,000
Q2 2018 Aug 15, 2018	SELL	$4.75 - $8.0 $90,335 - $152,144	-19,018 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$4.5 - $9.95 $84,888 - $187,696	-18,864 Reduced 49.8%	19,018 $98,000
Q4 2017 Feb 14, 2018	BUY	$1.75 - $3.8 $66,293 - $143,951	37,882	37,882 $144,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.